The online version of this article (doi:10.1186/1477-7827-10-2) contains supplementary material, which is available to authorized users.
and Keiichi Matsubara contributed equally to this work.
The authors declare that they have no competing interests.
YM collected all samples, carried out the molecular genetic studies, participated in the sequence alignment, and drafted the manuscript. KM carried out EPC isolation, LDL/lectin assay, and FACS analysis. KM also participated in the design of the study, performed the statistical analysis, and helped to review the manuscript. All authors read and approved the final manuscript.
It has been previously suggested that angiogenesis occurs during the menstrual cycle. Moreover, a rise in uterine blood flow is largely maintained by vasodilatation and substantial increases in angiogenesis. It is known that estradiol (E2) and progesterone (P4) are involved in angiogenesis. Recently, endothelial progenitor cells (EPCs) were found to be involved in neovascularization; however, their roles in uterine neovascularization have not been well characterized. We hypothesized that E2- or P4-mediated EPC proliferation plays important roles in uterine neovascularization during the menstrual cycle.
The number of EPCs in peripheral blood from subjects in the menstrual phase (n = 12), follicular phase (n = 8), and luteal phase (n = 16), was measured using flow cytometry. Peripheral blood mononuclear cells (PBMCs) were cultured for seven days with or without 17beta-estradiol (E2beta) or P4, followed by assessment of EPC proliferation based upon the uptake of acetylated low density lipoprotein (LDL) and lectin. The expression of estrogen receptor (ER) or progesterone receptor (PR) in EPCs was also evaluated using real-time PCR.
E2beta and P4 significantly increased the proliferation of EPCs derived from the peripheral blood of subjects in menstrual phase, but not subjects in the luteal phase. In addition, the expression level of ERalpha was markedly higher than ERbeta in EPCs derived from women in menstrual phase.
EPC proliferation is induced during the menstrual phase and proliferation can be affected by estrogen through ERalpha activation.
Authors’ original file for figure 112958_2011_944_MOESM1_ESM.jpeg
Authors’ original file for figure 212958_2011_944_MOESM2_ESM.jpeg
Authors’ original file for figure 312958_2011_944_MOESM3_ESM.jpeg
Authors’ original file for figure 412958_2011_944_MOESM4_ESM.jpeg
Authors’ original file for figure 512958_2011_944_MOESM5_ESM.jpeg
Authors’ original file for figure 612958_2011_944_MOESM6_ESM.jpeg
Magness RR, Zheng J: Maternal Cardiovascular Alterations During Pregnancy. Pediatrics and Perinatology. The Scientific Basis. Edited by: Gluckman PD, Heymann MA. 1996, Arnold Publishing, London, 762-772. 2
Magness RR: Maternal cardiovascular and other physiologic responses to the endocrinology of pregnancy. Endocrinology of Pregnancy. 1998, Fuller Bazer, Humana Press Inc, Totowa NJ, 18: 507-539. CrossRef
Perrot-Applanat M, Deng M, Fernandez H, Lelaidier C, Meduri G, Bouchard P: Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels. J Clin Endocrinol Metab. 1994, 78: 216-224. 10.1210/jc.78.1.216. PubMed
Carr BR, Wilson JD: Disorders of the ovary and the female reproductive tract. Harrison's Principles of Internal Medicine. Edited by: Braunwald E, Isselbacher KJ, Petersdorf RG, Nilson JD, Martin JB, Fauci AS. 1987, New York: McGraw-Hill, 1818-1837. 11
Baird DT, Fraser IS: Blood production and ovarian secretion rates of esuadiol-17β and estrone in women throughout the menstrual cycle. J Clin Endocrinol Metab. 1974, 38: l009-1017. CrossRef
King AG, Zheng J, Bird IM, Magness RR: Estrogen receptor (ER) -α and ER-β stimulation increases vascular endothelial growth factor secretion by ovine uterine artery endothelial cells. 35th Annual Meeting of the Society for the Study of Reproduction. 2002
Byers MJ, Chen DB, Phernetton TM, Bird IM, Magness RR: Endothelial Estrogen Receptor α and β Expression and Steroid Regulation in Ovine Uterine Arteries. 48th Annual Meeting of the Society for Gynecologic Investigation. 2001
Shekhar MPV, Werdell J, Tait L: Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res. 2000, 60: 439-449. PubMed
Rupnow HL, Phernetton TM, Shaw CE, Modrick ML, Bird IM, Magness RR: Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS. Am J Physiol Heart Circ Physiol. 2001, 280: H1699-H1705. PubMed
McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW: Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol. 1995, 9: 659-669. 10.1210/me.9.6.659. PubMed
Magness RR, Phernetton TM, Zheng J: Systemic and uterine blood flow distribution during prolonged infusion of 17β-estradiol. Am J Physiol. 1998, 275 (Heart Circ Physiol): H731-H743. PubMed
Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000, 28: 3422-3427. CrossRef
Peichev M, Naiyer A, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood. 2000, 95: 952-958. PubMed
Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW: Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation. 2003, 108: 3115-3121. 10.1161/01.CIR.0000106906.56972.83. CrossRefPubMed
Gussin H, Bischoff F, Hoffman R, Elias S: Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Invest. 2000, 9: 357-361. CrossRef
Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M: Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. ARJI. 2006, 56: 1-7.
Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R, Zhu Y, Qin G, Silver M, Thorne T, Eaton L, Masuda H, Asahara T, Losordo DW: Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation. 2006, 113: 1605-1614. 10.1161/CIRCULATIONAHA.105.553925. CrossRefPubMed
Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, Asai J, Tsutsumi Y, Sekiguchi H, Silver M, Wecker A, Bord E, Zhu Y, Kishore R, Losordo DW: Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 2006, 114: 2261-2270. 10.1161/CIRCULATIONAHA.106.631465. CrossRefPubMed
Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, Laufs K, Ghaeni L, Milosevic M, Böhm M, Nickenig G: Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 2003, 107: 3059-3065. 10.1161/01.CIR.0000077911.81151.30. CrossRefPubMed
Nakamura J, Lu Q, Aberdeen G, Albrecht E, Brodie A: The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland. J Clin Endocrinol Metab. 1999, 84: 1432-1437. 10.1210/jc.84.4.1432. PubMed
Flamme I, Risau W: Induction of vasculogenesis and hematopoiesis in vitro. Development. 1992, 116: 435-459. PubMed
- Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
e.Med Kampagnen-Visual, Mail Icon II